- Report
- March 2024
- 181 Pages
Global
From €2160EUR$2,450USD£1,884GBP
- Report
- November 2024
- 498 Pages
Global
From €4364EUR$4,950USD£3,806GBP
- Report
- July 2024
- 476 Pages
Global
From €4364EUR$4,950USD£3,806GBP
- Report
- September 2023
Global
From €4364EUR$4,950USD£3,806GBP
- Report
- January 2023
- 356 Pages
Global
From €4364EUR$4,950USD£3,806GBP
- Report
- November 2024
- 240 Pages
Global
From €2116EUR$2,400USD£1,845GBP
- Report
- May 2024
- 420 Pages
Global
From €2645EUR$3,000USD£2,307GBP
- Report
- February 2024
- 50 Pages
Global
From €2116EUR$2,400USD£1,845GBP
- Report
- December 2023
- 220 Pages
Global
From €2909EUR$3,300USD£2,537GBP
- Report
- October 2023
- 420 Pages
Global
From €2557EUR$2,900USD£2,230GBP
- Report
- June 2022
- 1500 Pages
Global
From €3438EUR$3,900USD£2,999GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €2645EUR$3,000USD£2,307GBP
- Report
- February 2022
- 360 Pages
United States
From €3174EUR$3,600USD£2,768GBP
- Report
- November 2021
- 222 Pages
Global
From €2645EUR$3,000USD£2,307GBP
- Report
- October 2021
- 78 Pages
Global
From €705EUR$800USD£615GBP
- Report
- August 2023
- 389 Pages
Global
From €3681EUR$4,175USD£3,210GBP
- Report
- May 2023
United States
From €992EUR$1,125USD£865GBP
€1322EUR$1,500USD£1,153GBP
- Report
- March 2023
Germany
From €992EUR$1,125USD£865GBP
€1322EUR$1,500USD£1,153GBP
- Report
- November 2022
- 197 Pages
United States
From €2480EUR$2,813USD£2,162GBP
€3306EUR$3,750USD£2,883GBP
- Report
- January 2022
- 292 Pages
Global
From €2480EUR$2,813USD£2,162GBP
€3306EUR$3,750USD£2,883GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more